Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
-
A-Mark Precious Metals Appoints Cary Dickson as Chief Financial Officer Effective July 1, 2025
-
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
-
FOREWARN to Provide Identity Verification Services to HiCentral MLS® to Promote Agent Safety
-
Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
-
Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
-
INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for Commercial Readiness
-
Berry Corporation Strengthens Executive Leadership Team with Appointment of General Counsel
-
Smalls Sliders Supercharges Their Data Strategy With Guest Insights From Bikky
-
Stockwik publishes annual report and sustainability report
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
JDE Peet’s share buyback periodic update April 14, 2025
-
ASML reports transactions under its current share buyback program
-
Unisize, a sizing recommendation software for fashion apparel e-commerce, releases a new demo of “FaceChange” AI Function
-
Volatus Aerospace Secures Extension to Service Agreement with Canadian Government
-
Guangxi Baise City's Beautiful Scenery "Charms" the United Nations
-
Stantec announces dates for first quarter 2025 results and conference call and annual general meeting of shareholders
-
Guangxi Baise City's Beautiful Scenery "Charms" the United Nations
-
Swarm Joins Hivello—Marking the 10th DePIN Network Aggregated
-
Keiretsu Forum Brings 13 High-Potential Startups to 2025 Angel Capital Association Innovation Funders Showcase
-
Qorvo® Announces Results of Board Refreshment Process
-
Relmada Therapeutics To Present NDV-01 Data at AUA2025
-
Montage Gold Exercises Participation Rights in Sanu Gold
-
American Tungsten Corp. Announces New CEO, Ali Haji
-
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario
-
Avicanna Reports Full Year 2024 Audited Financial Statement
-
New Poll: 9 in 10 Canadians Support Expanding Hydropower in Canada
-
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario
-
SEC Approves Green Impact Exchange’s Form 1 Application
-
Creative Realities Announces Participation in Upcoming Planet MicroCap Event
-
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
-
Dragonfly Energy’s Battle Born® Mobile App Now Available for Android Users
-
Auction result of Treasury Bills - RIKV 25 0716 - RIKV 25 1015
-
Futu Holdings Limited Announces Filing of Its Annual Report on Form 20-F for Fiscal Year 2024
-
Bitget Wallet Supports WalletConnect's Token Launch via WCT Activation
-
Bitget Wallet Supports WalletConnect's Token Launch via WCT Activation
-
Flow Capital Announces Early Repayment of Investment in the Civic Tech Space
-
ECARX Unveils ECARXperience: Revolutionizing In-Vehicle Interaction with Adaptive AI-Powered Driving Experience
-
MISTR Marks One Year of DoxyPEP Access with STI Positivity Rates Cut in Half
-
Osisko Metals Intersects 300 Metres Averaging 0.39% Copper at Gaspé Copper Project
-
SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)
-
StoneX to Acquire R.J. O’Brien, Creating a Market Leader in Global Derivatives
-
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
-
Aya Gold & Silver Announces Appointment of John Burzynski to the Board and Departure of Nikolaos Sofronis
-
Soleno Therapeutics Announces VYKAT(TM) XR Launch
-
Skye Bioscience to Conduct Meetings at Piper Sandler Conference
-
ASDS to Offer an Immersive Educational Course for Dermatologists to Strengthen Their Cosmetic Injection Expertise
-
Cielo Provides Update on Corporate Matters
-
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer
-
EnviroGold Global Advances NVRO Process for Strategic Resource Recovery of Rare Earth Minerals Unlocking Adding Value

